| 000 | 01399 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514022353.0 | ||
| 264 | 0 | _c20020314 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0250-8095 | ||
| 024 | 7 |
_a10.1159/000046657 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, S | |
| 245 | 0 | 0 |
_aCAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans. _h[electronic resource] |
| 260 |
_bAmerican journal of nephrology _c |
||
| 300 |
_a502-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlcaligenes |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPenicillanic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPenicillins _xtherapeutic use |
| 650 | 0 | 4 |
_aPeritoneal Dialysis, Continuous Ambulatory _xadverse effects |
| 650 | 0 | 4 |
_aPeritonitis _xdrug therapy |
| 650 | 0 | 4 |
_aPiperacillin _xtherapeutic use |
| 650 | 0 | 4 | _aTazobactam |
| 700 | 1 | _aCheng, C C | |
| 700 | 1 | _aTse, K C | |
| 700 | 1 | _aLi, F K | |
| 700 | 1 | _aChoy, B Y | |
| 700 | 1 | _aChan, T M | |
| 700 | 1 | _aLai, K N | |
| 773 | 0 |
_tAmerican journal of nephrology _gvol. 21 _gno. 6 _gp. 502-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000046657 _zAvailable from publisher's website |
| 999 |
_c11710217 _d11710217 |
||